• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Opportunities and Challenges to Adherence: A Field Experience
 

Opportunities and Challenges to Adherence: A Field Experience

on

  • 611 views

 

Statistics

Views

Total Views
611
Views on SlideShare
611
Embed Views
0

Actions

Likes
0
Downloads
7
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Opportunities and Challenges to Adherence: A Field Experience Opportunities and Challenges to Adherence: A Field Experience Presentation Transcript

    • Some Opportunities and Challenges to Adherence in PMTCT Fabienne Shumbusho, Family Health International Kigali, 19 October 2009
    • Follow-up of PMTCT Women in Ante-Partum Period Eligible to triple therapy
      • Indicators tracked and
      • reported
      • No indicators tracked
      • and reported
      • In 2008 (49 ART sites):
        • 1365 HIV+ women
        • 1336 HIV+ women received ART prophylaxis
        • 1258 deliveries and 89% at facility level
      ? ? ? Start of ART Week 5-6 Lab exams Every 2 weeks for 1 month Delivery at facility Labour & delivery 2 education sessions + additional lab exams (biochem; hematology) Week 4-5 Result CD4 count test (CD4 ≤ 350/mm 3 or stage IV or pregnancy ≥ 34 weeks) Week 2-3 Sample for CD4 Week 1 HIV test Hg RPR test 1 st contact (t 0 )
    • Follow-up of PMTCT Women in Ante-Partum Period Not eligible to triple therapy ? ? ? ? Lab exams Every 2 weeks for 1 month Delivery at facility Labour & delivery Every 3-6 months CD4 control Refills for ART prophylaxis Monthly Start of AZT ≥ 28 weeks pregnancy Result CD4 count test (CD4 > 350/mm 3 ) Week 2-3 Sample for CD4 Week 1 HIV test Hg RPR test 1 st contact (t 0 )
    • Follow-up of PMTCT Women in Intra & Post-Partum Period ? ? Every 3-6 months CD4 control Cotrimoxazole prophylaxis refills ART (if on txt) Each 4 weeks (monthly) AZT/3TC After delivery: for 7 days AZT/3TC/NVP During labour
    • Follow-up of PMTCT Infants in Intra & Post-Partum Period ? ? ? Cotrimoxazole prophylaxis refills Each 4 weeks (monthly) Result DBS/PCR +/- 10 weeks and over Immunization DBS/PCR Cotrimoxazole prophylaxis 6 weeks NVP SD at birth and AZT (>90%) Delivery up to 4 weeks
      • Opportunities
      • Big proportion of clients tested for HIV
      • We know how many start treatment (ART; CTX)
      • Availability of CD4 count machines in district hospitals
      • Scaling-up and task-shifting for ART
      • Challenges
      • Number of visits to HF (time spent at HF)
      • Home visits?
      • Not all sites offer ART
      • No reporting on refills
      • No indicators on CD4 count (proportion who get their results; controls)
      • Pre-ART
      • Thank you